SCHEMBL7963844

SCHEMBL7963844

OC1(c2ccc(Cl)cc2F)CCN(CCCc2nnc3n2CCCCC3)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
SHMT2 P34897 1/20 0.45
HSD11B1 P28845 5/20 0.45
HSD11B2 P80365 2/20 0.45
GAA P10253 2/20 0.44
DRD2 P14416 6/20 0.43
HPGD P15428 2/20 0.43
POLB P06746 1/20 0.43
PKM P14618 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
HTR1A P08908 3/20 0.40
HTR2A P28223 3/20 0.40
DRD3 P35462 3/20 0.40
SLC6A4 P31645 2/20 0.40
HTR2B P41595 2/20 0.40
HTR7 P34969 2/20 0.40
DRD1 P21728 1/20 0.40
DRD5 P21918 1/20 0.40
SLC6A2 P23975 1/20 0.40
HRH1 P35367 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7960165 0.89 PKM (0.52) LMNASHMT2HSD11B1HSD11B2GAA
SCHEMBL7957371 0.85 LMNA (0.52) LMNASHMT2HSD11B1HSD11B2GAA
SCHEMBL7959708 0.84 DRD2 (0.55) HSD11B1HSD11B2DRD2HTR1AHTR2A
SCHEMBL7959210 0.83 DRD2 (0.45) LMNASHMT2GAADRD2HPGD
SCHEMBL7959714 0.83 GAA (0.50) LMNASHMT2HSD11B1GAADRD2
SCHEMBL7957105 0.83 DRD2 (0.46) LMNASHMT2HSD11B1HSD11B2GAA
SCHEMBL7959533 0.81 DRD2 (0.48) LMNASHMT2HSD11B1HSD11B2GAA
SCHEMBL7963703 0.81 HSD11B1 (0.41) LMNASHMT2HSD11B1HSD11B2GAA
SCHEMBL7963490 0.79 LMNA (0.46) LMNASHMT2HSD11B1HSD11B2GAA
SCHEMBL7957541 0.78 OPRM1 (0.58) DRD2HTR1AHTR2ADRD3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed